Previous studies reported that BRAF, KRAS, and NRAS mutations occur in 10%–15% [2, 35, 36, 47], 35–40% [36, 37, 42, 48], and 2–7% of colorectal cancers [42, 49], respectively. This evidence concerns the gene KRAS and colorectal cancer.